Skip to content
‹ Back to IndustriesHealthcare

Unlock Hidden Potential in Healthcare: Data-Driven Benchmarks Reveal Efficiency Gains in Reviews

Annalise Ludtke from Vodori discusses the importance of data-driven benchmarks in healthcare promotional review processes. The conversation features insights from Scott Rovegno, exploring strategies for improving efficiency and effectiveness in medical product commercialization. The session emphasizes using performance measurement to enhance healthcare operations.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Vodori on MarketScale.

By Annalise Ludtke · · Annalise LudtkeHealthcare industryHealthcare StrategyPromotional Review Process
Share
Unlock Hidden Potential in Healthcare: Data-Driven Benchmarks Reveal Efficiency Gains in Reviews

Key takeaways

01

Promotional review processes benefit significantly from data-driven benchmarks.

02

Improving operational efficiency in healthcare requires continuous performance measurement.

03

Strategic insights facilitate the advancement of healthcare product commercialization.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

In an era where the healthcare industry is increasingly data-driven, understanding the nuances of promotional review processes becomes crucial for innovation and efficiency. The Benchmarks Symposium hosted by Vodori provides a deep dive into the state of promotional review benchmarks in 2023.

This episode led by Annalise Ludtke, the Senior Manager of Marketing and Communications at Vodori, features a conversation with Scott Revegno, Co-founder and CEO of Vodori. They explore the importance of data and benchmarks in the promotional review process, discussing strategies for continuous improvement and operational efficiency. Through their dialogue, they underscore the critical role of measuring performance to effectively manage and enhance medical product commercialization.

Vodori

Part of this channel

Vodori

Faster market access through compliant life science content review.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

AL
Annalise Ludtke
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Moderna swings to a profit and raises its 2026 revenue outlook as newer vaccines gain traction

Moderna swings to a profit and raises its 2026 revenue outlook as newer vaccines gain traction

Moderna reported third-quarter revenue of $1.31 billion, up 29%, and net income of $162 million, compared with a $200 million loss a year earlier. International COVID vaccine sales under long-term government partnerships and the full-year impact of its next-generation COVID vaccine drove growth, while lower costs helped the profit. The company raised its 2026 revenue growth outlook to 15% to 25% from up to 10%. Its flu shot, mFLUSIVA, was approved in the U.S. and will have a limited U.S. launch in 2026.

  • 01Third-quarter revenue rose 29% to $1.31 billion, with $780 million in the U.S. and $533 million internationally.
  • 02Net income was $162 million, or 38 cents per share, versus a $200 million loss a year earlier.
  • 03Moderna now expects 2026 revenue growth of 15% to 25%, up from up to 10%.

Nov 6, 2026

Why legacy EHR data decides whether healthcare AI pays off

Why legacy EHR data decides whether healthcare AI pays off

MediQuaid director of client services Jason Tennison, a former bedside nurse, discussed EHR replacement data challenges on the Scopewell podcast, where host James Leuthe credited him with an analogy that clean, governed data is the foundation AI needs. Clearsense says a national health system retired more than 800 legacy systems and generated over $100 million in recurring annual operating savings by archiving inactive records, and Harmony Healthcare IT’s 2023 CHIME CIO survey found 94% still operating on legacy applications.

  • 01A national health system retired more than 800 legacy systems and booked over $100 million in recurring annual operating savings by archiving inactive records, Clearsense says.
  • 02Harmony Healthcare IT's 2023 survey of health care CIOs found 94% still run legacy applications, and the average hospital carries 10 EHRs.
  • 03Across industries, 52% of chief data officers rate their generative AI data readiness inadequate, per an AWS and Harvard Business Review survey reported by HealthTech Magazine.

Nov 6, 2026

Censis now reads da Vinci 2D codes to count arm uses

Censis now reads da Vinci 2D codes to count arm uses

Censis Technologies told CtUC 2026 attendees that CensiTrac has read the 2D matrix code on da Vinci arms since April, so robotic arms carry use counts without a second mark. The session built a business case for CensiTrac Advanced around marked assembly, clinic inventory ownership and par levels, with a 2021 BMJ Quality & Safety study putting missing instruments at 17.6% of assembly defects.

  • 01CensiTrac has counted da Vinci arm uses from the code that already comes on each arm since April, with no laser or etch added.
  • 02Hospitals told Censis they want clinic inventory tracking mainly to prove sterile processing did not lose the instruments.
  • 03Missing instruments were 17.6% of assembly tray defects at a 700-bed hospital in a 2021 BMJ Quality & Safety study, a problem the presenter tied to marked assembly.

Nov 5, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

AL
Annalise Ludtke

Senior Manager of Marketing and Communications at Vodori

Annalise Ludtke is responsible for shaping marketing and communications strategies at Vodori. Her work focuses on enhancing the efficiency of promotional review processes in the healthcare sector. She plays a key role in leveraging data-driven insights to drive operational improvements.

SR
Scott Rovegno

Co-founder and CEO

Vodori

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512